Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.7000 (3.64%) ($5.1000 - $5.7000) on Tue. Mar. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.81% (three month average) | RSI | 70 | Latest Price | $5.7000(3.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) UNG(11%) BNDX(8%) TLT(8%) PCY(7%) BWX(6%) | Factors Impacting CAPR price | CAPR will decline at least -3.405% in a week (0% probabilities). XME(-21%) XRT(-20%) XHB(-19%) JNK(-19%) IVW(-19%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.405% (StdDev 6.81%) | Hourly BBV | 0 () | Intraday Trend | 5.4% | | | |
|
5 Day Moving Average | $5.69(0.18%) | 10 Day Moving Average | $5.5(3.64%) | 20 Day Moving Average | $5.08(12.2%) | To recent high | -16.2% | To recent low | 14% | Market Cap | $112m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |